Non-interventional Study Related to Fixed LAMA/LABA/ICS Triple Therapy
NCT04355546 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 94
Last updated 2023-08-02
Summary
This is a prospective non-interventional trial to measure the health related quality of life of patients with chronic obstructive pulmonary disease (COPD) on a fixed LAMA/LABA/ICS triple therapy (Trimbow®) and characterisation of determinants of treatment adherence.
Conditions
Interventions
- OTHER
-
Non-interventional
As this is a Non-interventional trial, only data obtained within the current routine management of COPD at outpatient respiratory centres or GP centres will be documented.
Sponsors & Collaborators
-
Liverpool Heart and Chest Hospital NHS Foundation Trust
collaborator OTHER -
Chiesi UK
lead INDUSTRY
Eligibility
- Min Age
- 35 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-15
- Primary Completion
- 2022-06-09
- Completion
- 2022-06-09
Countries
- United Kingdom
Study Locations
More Related Trials
-
Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]
NCT03265145 ·Status: COMPLETED ·Phase: PHASE4
-
Lung Deposition of TRIMBOW® pMDI in Healthy Volunteers, Asthmatic and COPD Patients
NCT03795350 ·Status: TERMINATED ·Phase: PHASE1
-
Impact of Fixed TRIple Therapy With Beclometasone/Formoterol/Glycopyrronium DPI (Trimbow® in NEXThaler Device) in Chronic Obstructive PulmoNary Disease in rEal-world Settings: Health-related Quality of Life Patient' eXpectations and characterisTics: the TriNEXT Study
NCT05948891 ·Status: RECRUITING
-
TRIMBOW® and RELVAR® on Lung Stiffness Reduction Assessed Through Forced Oscillation Technique in Patients With COPD
NCT04671355 ·Status: WITHDRAWN ·Phase: PHASE4
-
Triple Therapy Convenience by the Use of One or Multiple Inhalers and Digital Support in Chronic Obstructive Pulmonary Disease
NCT05495698 ·Status: RECRUITING ·Phase: NA
-
Tiotropium in Patients With Tuberculosis (TB) Destroyed Lung
NCT01365702 ·Status: UNKNOWN
-
Phase 1/Phase 2a Study of AERO-007 Inhalation Solution, a Nebulized LABA/LAMA Combination for Maintenance Treatment of COPD
NCT06841640 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)
NCT06234345 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Study in Healthy Adults to Quantify Lung Deposition and Distribution of Radio-labelled S-770108 Inhalation Powder Formulation Delivered by a Novel Inhaler Device
NCT04631354 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating Fosfomycin/Tobramycin for Inhalation in Cystic Fibrosis Patients With Pseudomonas Aeruginosa Lung Infection
NCT00794586 ·Status: COMPLETED ·Phase: PHASE2
-
Real-World Effectiveness of a Triple Combination BDP/FF/GB in a Single Pressurised Metered Dose Inhaler in COPD Patients (TRIPHY)
NCT06480890 ·Status: COMPLETED
-
Study of Trospium Chloride Inhalation Powder (TrIP) in Patients With Chronic Obstructive Pulmonary Disease
NCT00465959 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparative Effectiveness of Symbicort vs. Spiriva Among COPD Patients
NCT01917643 ·Status: COMPLETED
-
To Evaluate the Safety, Tolerability, Pulmonary Deposition, Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Inhale in Japanese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD, GOLD II-III)
NCT01072942 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis
NCT03903913 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase I Study to Assess Safety, Tolerability, PK and PD of AGMB-447 in Healthy Participants and Participants With IPF
NCT06181370 ·Status: RECRUITING ·Phase: PHASE1
-
Effect of Spacer Use on Exacerbation Risk in High-Risk Older Adults With Chronic Airway Diseases Receiving Triple Therapy
NCT07030881 ·Status: RECRUITING ·Phase: NA
-
Sequential Segmental Treatment of Emphysema With Upper Lobe Predominance (STEP-UP) Study
NCT01719263 ·Status: COMPLETED ·Phase: NA
-
OTIVACTO Spain Non Interventional Study
NCT02927795 ·Status: COMPLETED
-
Single Use Bronchoscopes for Interventional Pulmonology
NCT06596655 ·Status: RECRUITING ·Phase: NA
-
A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis
NCT06280391 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device Robustness
NCT03137992 ·Status: COMPLETED ·Phase: PHASE3
-
Switching From Tobramycin Inhalation Treatment to Tobramycin Inhaler Treatment: The Effect on CF Patients' Adherence and Quality of Life
NCT01749644 ·Status: UNKNOWN
-
Nasal Muco-ciliary Clearance Study With and Without Salt Inhalation
NCT04189016 ·Status: UNKNOWN ·Phase: NA
-
Comparing Maintenance of Device Mastery With Turbohaler© vs. Spiromax© in Healthcare Professionals naïve to Both Devices
NCT02570425 ·Status: COMPLETED ·Phase: NA